Elionova AG is a Swiss biotechnology company founded in September 2020. Headquartered in Fribourg, Switzerland, Elionova specializes in the development of cutting-edge immunodiagnostic solutions.

 

Driven by serial entrepreneurs & diagnostics experts Elionova is led by a multidisciplinary team with complementary expertise across key scientific and entrepreneurial domains.

 

With a strong commitment to innovation and a broad international network, our collective strength is further amplified by collaboration with advisors from various disciplines.